<DOC>
	<DOCNO>NCT00789880</DOCNO>
	<brief_summary>This study examine whether administration oral Vitamin D3 give 21 day change antimicrobial peptide expression skin saliva subject Atopic Dermatitis ( AD ) . This study help researcher determine lack expression antimicrobial peptide individual AD play role susceptibility eczema vaccinatum ( EV ) .</brief_summary>
	<brief_title>Analysis Response Subjects With Atopic Dermatitis Psoriasis Oral Vitamin D3</brief_title>
	<detailed_description>Atopic Dermatitis ( AD ) chronic inflammatory skin disorder skin become extremely itchy susceptible recurrent skin infection . AD think occur combination immunological , genetic , environmental factor . Individuals AD risk develop severe widely disseminate infection call eczema vaccinatum ( EV ) . EV cause live attenuate vaccinia virus vaccine reproduce spread throughout body . Individuals AD lack certain antimicrobial peptide , specifically cathelicidins . This trial also include sub-study individual psoriasis . Psoriasis also immune-mediated skin disease , characterize scale skin inflammation ( pain , swell , heat , redness ) . Most psoriasis cause patch thick , red skin silvery scale . These patch itch feel sore . This sub-study provide additional information psoriatic response oral vitamin D. ( Originally list separately ADVN-CATH-03-01 , NCT : 01078259ID . )</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Inclusion Criteria ( Main Study ) : Definitive diagnosis AD least 6 month , stringently diagnose use ADVN Standard Diagnostic Criteria , lesional skin present OR nonatopic healthy control subject personal family history food allergy , AD , asthma , allergic rhinitis Residing US . Inclusion Criteria ( SubStudy ) : Definitive diagnosis typical plaque psoriasis least 6 month , stringently diagnose use ADVN Standard Diagnostic Criteria ; AD nonatopic healthy control subject participate main protocol ADVN CATH 03 . Residing US . Exclusion Criteria ( Main Study ) : Presence atopy without stringent AD feature , allow presumptive diagnosis AD Presence AD exfoliative erythroderma Presence psoriasis Pregnant lactating female Existence ongoing dental disease ( e.g. , gingivitis ) History bleed disorder Presence severe AD would exacerbate withhold topical corticosteroid , oral topical antibiotic , topical systemic antihistamine , oral antiviral , immune enhancer ( e.g. , imiquod ) , topical calcineurin inhibitor within 7 day Study Visit 2 ( Baseline ) throughout course trial Receiving systemic immunosuppressive , chemotherapeutic agent , antiinflammatory biologics ( e.g. , alefacept , etanercept ) , systemic , oral , injectable inhaled steroid , vitamin D supplement ( 400 IU daily ) oral calcineurin inhibitor 30 day prior Study Visit 2 ( Baseline ) anytime course trial Using topical corticosteroid , oral topical antibiotic , oral antiviral , immune enhancer ( e.g. , imiquimod ) , topical systemic antihistamine , topical calcineurin inhibitor within 7 day Study Visit 2 ( Baseline ) course trial Receiving phototherapy ( e.g. , UVB , psoralen plus ultraviolet light A [ PUVA ] ) within 30 day Study Visit 2 ( Baseline ) course trial Having autoimmune immunodeficiency disease Presence active systemic fungal ( exclude nail fungus ) , bacterial , viral infection History presence active systemic malignancy , exclude uncomplicated nonmelanoma skin cancer Mental illness history drug alcohol abuse , opinion investigator , would interfere participant 's ability comply study requirement Inability unwillingness participant give write informed consent Diabetes Certain screen laboratory value within normal limit , would include calcium , serum PTH , serum creatinine History kidney disease kidney stone Currently take barbiturate phenobarbital ( Luminal ) Currently take carbamazine ( Tegretol ) , digoxin , phenytoin ( Dilantin ) fosphenytoin ( cerebyx ) Currently take diuretic thiazide diuretic , calcium channel blocker , betablockers Currently take magnesiumcontaining antacid , mineral oil , cholestyramine ( Questran ) , colestipol ( Colestid ) , oristat ( xenical ) , fat substitute Olestra , cod liver oil , fish oil , omega 3 fatty acid Currently take oral antifungal ketoconazole History serious lifethreatening anaphylactic reaction tape adhesives Lidocaine allergy History active hyperparathyroidism , sarcoid , tuberculosis lymphoma . Exclusion Criteria ( SubStudy ) : Presence AD exfoliative erythroderma Presence psoriasis exfoliative erythroderma presence guttate psoriasis , primary palmoplantar psoriasis , pustular psoriasis Pregnant lactating female Existence ongoing dental disease ( e.g. , gingivitis ) History bleed disorder Presence psoriasis would severely exacerbated withhold topical corticosteroid , oral topical antibiotic , topical systemic antihistamine , oral antiviral , immune enhancer ( e.g. , imiquod ) , topical calcineurin inhibitor within 7 day Study Visit 2 ( Baseline ) throughout course trial Receiving systemic immunosuppressive , chemotherapeutic agent , antiinflammatory biologics ( e.g. , alefacept , etanercept ) , systemic , oral , injectable , inhaled steroid , vitamin D supplement ( 400 IU daily ) , oral calcineurin inhibitor , 30 day prior Study Visit 2 ( Baseline ) anytime course trial Using topical corticosteroid , oral topical antibiotic , oral antiviral , immune enhancer ( e.g. , imiquimod ) , topical systemic antihistamine , topical calcineurin inhibitor within 7 day Study Visit 2 ( Baseline ) course trial Receiving phototherapy ( e.g. , UVB , psoralen plus ultraviolet light A [ PUVA ] ) within 30 day Study Visit 2 ( Baseline ) course trial Having autoimmune immunodeficiency disease Presence active systemic fungal ( exclude nail fungus ) , bacterial , viral infection History presence active systemic malignancy , exclude uncomplicated nonmelanoma skin cancer Mental illness history drug alcohol abuse , opinion investigator , would interfere participant 's ability comply study requirement Inability unwillingness participant give write informed consent Diabetes Screening laboratory value within normal limit , would include calcium , serum PTH , serum creatinine History kidney disease kidney stone Currently take barbiturate pheonobarbital ( Luminal ) Currently take carbamazepine ( Tegretol ) , digoxin , phenytoin ( Dilantin ) fosphenytoin ( cerebyx ) Currently take diuretic thiazide diuretic , calcium channel blocker , betablockers Currently take magnesiumcontaining antacid , mineral oil , cholestyramine ( Questran ) , colestipol ( Colestid ) , oristat ( xenical ) , fat substitute Olestra , cod liver oil , fish oil , omega 3 fatty acid Currently take oral antifungal ketoconazole History serious lifethreatening anaphylactic reaction tape adhesives Lidocaine allergy History active hyperparathyroidism , sarcoid , tuberculosis lymphoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Vitamin D3</keyword>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Antimicrobial Peptide Expression</keyword>
</DOC>